Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- MHRA guidance on transition
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Use of the Moderna COVID-19 vaccine or ‘Spikevax’ has been approved for 6 to 11s after meeting the required safety, quality and effectiveness standards
Valneva COVID-19 vaccine approved by MHRA
Press release
An approval has been granted after the Valneva COVID-19 vaccine was found to meet the required safety, quality and effectiveness standards.
The decision to grant approval for this treatment was endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence.
A reflection by Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency
Coronavirus (COVID-19) vaccines adverse reactions
Research and analysis
A weekly report covering adverse reactions to approved COVID-19 vaccines
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- Consultation on proposal to make Aquiette 2.5mg Tablets (oxybutynin hydrochloride) available from pharmacies
- Consultation on a new Code of Practice for the Expert Advisory Committees
Transparency and freedom of information releases
- MHRA: policy for handling conflicts of interest
- Freedom of Information responses from the MHRA - week commencing 25 October 2021
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom
Corporate information
Jobs and contracts